CT-500

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCT-500
Drug Alias NameCT-400 (Creabilis Therapeutics)HMGB1 antagonists (Creabilis/Nautilus)HMGB1 antagonists (Creabilis/Nautilus)HMGB1 antagonists (Creabilis/Nautilus)HMGB1 antagonists (Creabilis/Nautilus) +[9] 
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAutoimmune DiseasesCardiovascular DiseasesNervous System Diseases +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCreabilis Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNautilus BiotechCreabilis Sa
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesCardiovascular DiseasesNervous System Diseases +[6] 

Other Information

ATC CodeN/A
Related LinksN/A